Inventor · disambiguated record
Mark C. Willingham
Also filed as: WILLINGHAM MARK · WILLINGHAM MARK C
12 granted patents·7 pending applications·616 citations·filing 1982–2022
94Inventor score
Top patents by PatentIndex Score
19 records- 0197US4545985APseudomonas exotoxin conjugate immunotoxinsUS HEALTH·Filed 1984·Granted Oct 8, 1985·160 cites·16 claims
- 0294US5608039ASingle chain B3 antibody fusion proteins and their usesUS HEALTH·Filed 1994·Granted Mar 4, 1997·163 cites·18 claims
- 0384US5242813AMouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumorsUS HEALTH·Filed 1990·Granted Sep 7, 1993·51 cites·8 claims
- 0483US5320956AMonoclonal antibody useful for the diagnosis of cancerUS HEALTH·Filed 1992·Granted Jun 14, 1994·56 cites·13 claims
- 0580US4958009AAnti-human ovarian cancer immunotoxins and methods of use thereofCETUS CORP·Filed 1987·Granted Sep 18, 1990·46 cites·19 claims
- 0676US5846535AMethods for reducing tumor cell growth by using antibodies with broad tumor reactivity and limited normal tissue reactivityUS HEALTH·Filed 1995·Granted Dec 8, 1998·27 cites·10 claims
- 0774US5990296ASingle chain B3 antibody fusion proteins and their usesUS HEALTH·Filed 1996·Granted Nov 23, 1999·37 cites·2 claims
- 0873US5525337AMonoclonal antibody binding cell surface antigens for diagnosing cancerUS HEALTH·Filed 1994·Granted Jun 11, 1996·35 cites·8 claims
- 0968US5817313AMonoclonal antibodies and conjugates thereof useful for the treatment of cancerUS HEALTH·Filed 1996·Granted Oct 6, 1998·26 cites·4 claims
- 1065US2007113298A1Genetically determined mouse model of resistance to transplantable cancersCUI ZHENG·Filed 2006·Application pending·0 cites
- 1162US2005022258A1Genetically determined mouse model of resistance to transplantable cancersFiled 2004·Application pending·0 cites
- 1256US2023010020A1Automated talent usage rights negotiation & management toolWILLINGHAM MARK·Filed 2022·Application pending·0 cites
- 1355US2012276013A1Genetically determined mouse model of resistance to transplantable cancersCUI ZHENG·Filed 2012·Application pending·0 cites
- 1454US2008089875A1Methods and compositions for the treatment of cancerCUI ZHENG·Filed 2007·Application pending·0 cites
- 1545US4806494AMonoclonal antibody against ovarian cancer cells (OVB-3)US DEPARTMENT OF HEALTH & HUMA·Filed 1986·Granted Feb 21, 1989·10 cites·5 claims
- 1645US2012107293A1Methods and compositions for the treatment of cancerCUI ZHENG·Filed 2011·Application pending·0 cites
- 1744US2010300804A1Di-Electric Harness For Fall Arrest SystemsWEB DEVICES LLC·Filed 2010·Application pending·0 cites
- 1840US4396628AAntiviral activities of dansylcadaverine and closely related compoundsUS DEPARTMENT OF HEALTH & HUMA·Filed 1982·Granted Aug 2, 1983·5 cites·3 claims
- 1931US5612032AMethod for diagnosing tumors using mouse monoclonal antibodiesUS HEALTH·Filed 1994·Granted Mar 18, 1997·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Mark C. Willingham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →